World's Best Scientists 2026 revealed!
Seminars in Oncology
H-index 15

Seminars in Oncology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1816 58 55 14

Additional Metrics

Number of Best Scientists*: 64
Documents by Best Scientists*: 61
Top 100 Ranked Scientists*: 0
SCIMAGO H-index: 149
SCIMAGO SJR: 1.202
Impact Factor: 2.5

Overview

Top Research Topics at Seminars in Oncology?

Seminars in Oncology focuses on Internal medicine, Oncology, Chemotherapy, Surgery and Cancer. The journal features Internal medicine research that overlaps with concepts in Gastroenterology. The concepts on Oncology presented in Seminars in Oncology can also apply to other research fields, including Combination chemotherapy, Cisplatin, Immunology, Carcinoma and Disease.

The in-depth study on Immunology also explores topics in the intersecting field of Cancer research. Many of the studies tackled connect Chemotherapy with a similar field of study like Regimen. It focuses on Surgery as well as the interrelated topic of Metastasis.

Cancer research featured in Seminars in Oncology incorporates concerns from various other topics such as Pathology and Intensive care medicine. Paclitaxel research presented in the journal encompasses a variety of subjects, including Neutropenia and Toxicity. The majority of Radiation therapy studies in the journal are focused on the subject of Combined Modality Therapy.

  • Internal medicine (49.56%)
  • Oncology (40.42%)
  • Chemotherapy (28.13%)

What are the most cited papers published in the journal?

  • Role of angiogenesis in tumor growth and metastasis (2191 citations)
  • Hereditary Colorectal Cancer (1800 citations)
  • Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia (692 citations)

Research areas of the most cited articles at Seminars in Oncology:

The most cited papers focus on Internal medicine, Oncology, Chemotherapy, Cancer and Immunology. Gastroenterology and Surgery are some topics wherein Internal medicine research discussed in the published papers has an impact. The works on Oncology tackled in the journal articles bring together disciplines like Combination chemotherapy, MEDLINE and Carcinoma, Disease, Pathology.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Disease

The previous edition focused in particular on these issues:

Seminars in Oncology investigates areas of study like Internal medicine, Cancer, Oncology, Pancreatic cancer and Chemotherapy. In it, Cancer research, Antibody, Retrospective cohort study and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are investigated in conjunction with one another to address concerns in Cancer research. The studies on Cancer research discussed can also contribute to research in the domains of Targeted therapy, Triple-negative breast cancer, KRAS and Immunotherapy.

Seminars in Oncology explores issues in Oncology which can be linked to other research areas like Precision medicine, Clinical trial, Disease, Gemcitabine and Colorectal cancer. Seminars in Oncology facilitates discussions on Pancreatic cancer that incorporate concepts from other fields like Gastrointestinal tumors, Resection, Review article and General surgery. Seminars in Oncology addresses concerns in Chemotherapy which are intertwined with other disciplines, such as Discontinuation, Peripheral neuropathy and Radiation therapy.

The most cited articles from the last journal are:

  • Cancer diagnosis in Brazil in the COVID-19 era. (6 citations)
  • Two decades of research toward the treatment of locally advanced and metastatic pancreatic cancer: Remarkable effort and limited gain. (3 citations)
  • KRAS mutation in pancreatic cancer. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Seminars in Oncology (based on the number of publications) are:

  • Gabriel N. Hortobagyi (38 papers) absent at the last edition,
  • Robert F. Ozols (31 papers) absent at the last edition,
  • Gloria J. Morris (31 papers) absent at the last edition,
  • Everett E. Vokes (30 papers) absent at the last edition,
  • John D. Hainsworth (30 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Seminars in Oncology (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (320 papers) absent at the last edition,
  • Memorial Sloan Kettering Cancer Center (261 papers) published 2 papers at the last edition,
  • Harvard University (180 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • University of Chicago (130 papers) absent at the last edition,
  • National Institutes of Health (121 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 12.50% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 17.86% were posted by at least one author from the top 10 institutions publishing in the journal. Another 3.57% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 32.14% of all publications and 46.43% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Educational Pathways in Oncology

For medical practitioners interested in diving into the fields of oncology, internal medicine, and cancer research, a proper educational background and training is of utmost importance. Along with continuous research engagement, the pursuit of higher education in relevant fields is vital. This not only equips one with requisite knowledge, but also ensures they are kept abreast of latest advances in this constantly evolving field.

For instance, if a medical professional aspires to specialize in the field of oncology nursing, they will need to consider obtaining further education in this specific area. A bachelor's degree in nursing (BSN) is typically the first step, followed by a Master’s of Science in Nursing (MSN) or even a Doctor of Nursing Practice (DNP) with a specialization in oncology could be beneficial.

Many universities and educational institutions offer these programs. A thorough research on the available options and making an educated choice will go a long way in establishing a successful career in the field. For instance, the best online nursing programs in Maryland offer comprehensive and flexible programs for both aspiring and practicing nurses who wish to specialise in oncology.

This extended education, coupled with a rigorous clinical experience, can enhance not just the understanding but also the practical treatment approaches of various conditions under the expansive umbrella of oncology.

Top Publications

  • Axillary surgery in breast cancer: An updated historical perspective.

    Francesca Magnoni;Viviana Galimberti;Giovanni Corso;Mattia Intra

    (2020)
    81 Citations
  • Implications of reactive oxygen species on cancer formation and its treatment.

    Manish A. Shah;Harry A. Rogoff

    (2021)
    62 Citations
  • Are sex discordant outcomes in COVID-19 related to sex hormones?

    Jonathan D. Strope;Cindy H. Chau;William D. Figg

    (2020)
    48 Citations
  • Novel radiation therapy approaches for breast cancer treatment.

    Chirag Shah;Kristine Bauer-Nilsen;Ryan Hazard McNulty;Frank Vicini

    (2020)
    45 Citations
  • Management of hormone receptor-positive, HER2-negative early breast cancer

    Elaine M. Walsh;Karen L. Smith;Vered Stearns

    (2020)
    37 Citations
  • Current and coming challenges in the management of the survivorship population.

    Eric J. Chow;Eric J. Chow;Kirsten K. Ness;Gregory T. Armstrong;Nickhill Bhakta

    (2020)
    33 Citations
  • Homologous recombination repair deficiency as a therapeutic target in sarcoma.

    Jay Oza;Sahil D. Doshi;Luke Hao;Elgilda Musi

    (2020)
    30 Citations
  • Management of ER positive metastatic breast cancer.

    Nicholas P. McAndrew;Richard S. Finn

    (2020)
    29 Citations
  • Homologous recombination repair deficiency as a therapeutic target in sarcoma.

    (2020)
    26 Citations
  • PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics

    (2023)
    20 Citations

Related Online Degrees & Career Pathways

For those interested in medical careers beyond traditional MD programs, several online degree options offer flexible pathways. Exploring how to become nurse practitioner roles can help candidates fast-track their healthcare careers while providing vital patient care. Many programs focus on specialized areas such as psychiatric nursing, where understanding psychiatric mental health nurse practitioner salary by state is essential for informed career planning.

Accelerated BSN programs present an opportunity for registered nurses to earn their Bachelor of Science in Nursing quickly, often within six months, opening doors to advanced practice and leadership roles. Similarly, ADN to FNP bridge programs allow nurses with an Associate Degree in Nursing to pursue a Master of Science in Nursing and become family nurse practitioners, expanding clinical expertise and patient impact.

Together, these alternative education routes create diverse career pathways in healthcare, aligning with personal goals and market demands. Including these options alongside traditional medicine studies can help prospective healthcare professionals tailor a path that fits their lifestyle and aspirations.

Best Scientists Contributing to This Journal